NCT05663073View on ClinicalTrials.gov

Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

December 15, 2022

Study Completion Date

April 21, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Irbesartan/Amlodipine FDC

Irbesartan/Amlodipine FDC

DRUG

Irbesartan

Co-administration of Irbesartan and Amlodipine

DRUG

Amlodipine

Co-administration of Irbesartan and Amlodipine

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY